Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study

Table 5

Number of patients using symptomatic medications during the 2008 grass pollen season (the reference season) and discontinuing these symptomatic medications during the 2009 season (the first year of SLIT).

Type of medication	Symptomatic medication use during the pollen season
	Medication used in 2008	Medication used in 2008 and discontinued during SLIT in 2009
		(%)
Eye drops	209	149 (71.3)
Nasal antihistamines	150	129 (86.0)
Oral antihistamines	388	222 (57.2)
Nasal corticosteroids	135	95 (70.4)
Oral corticosteroids	28	26 (92.9)
Inhaled corticosteroids	64	39 (60.9)
Inhaled beta-2 adrenoceptor agonists	69	37 (53.6)

: number of patients; %: percentage of patients.